Introduction
Spontaneous regression of cancer was first defined in 1959 by Cole and Everson as partial or complete disappearance of a malignant tumor in the absence of all treatment, or in the presence of therapy, which is considered to be inadequate to exert a significant influence on neoplastic disease. 1 Malignant tumors that can convert to spontaneous regression included neuroblastoma, renal cell carcinoma, choriocarcinoma, liver cancer, etc. [2] [3] [4] Unfortunately, spontaneous regression of hepatocellular carcinoma (HCC) is a rare event, 5 and the underlying cause of this remission remains obscure. Several mechanisms have been suggested to explain the etiology of spontaneous regression of HCC, including tumor ischemia, systemic inflammatory activation, temperance, drugs, and other mechanisms. 6 Ischemia and inflammation are the main mechanisms. 7 However, only 28.0% spontaneous regression of HCC can be attributed to tumor ischemia. 7 Many regression cases (33.3%) are due to a systemic inflammatory response, such as cholangitis and elevated cytokine levels. [7] [8] [9] However, the histological diagnosis has not been done in most cases; in particular, the pathological operation resection has not been performed. This lack of diagnosis causes the systemic inflammatory response hypothesis to be insufficient.
In the present study, we report on a patient who had a spontaneous regression of HCC without any evidence of ischemia. We found the generating process of spontaneous regression of HCC in pathological examination after surgical resection.
Materials and methods
A patient was identified who had a spontaneous regression of HCC at The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China. The submit your manuscript | www.dovepress.com
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Wang et al patient's clinical features, plain computed tomography (CT), and pathological features were recorded. The patient with the spontaneous regression of HCC was then treated with surgical resection. The resected specimens were fixed in 10% buffered formalin and embedded in paraffin. An immunohistochemical study was performed using the following primary antibodies: CD68 (FLEX Ready-to-Use [RTU]; Dako Denmark A/S, Glostrup, Denmark); CD163 (RTU; Leica Microsystems, Wetzlar, Germany); CD20 (diluted 1:1,000; Dako Denmark A/S); CD79a (RTU; Dako Denmark A/S); CD3 (RTU; Dako Denmark A/S); CD5 (RTU; Dako Denmark A/S); CD4 (diluted 1:100; OriGene, Rockville, MD, USA); CD8 (diluted 1:500; Nobel Biocare, Zurich, Germany); CD56 (RTU; Dako Denmark A/S); Granzyme B (RTU; Dako Denmark A/S); and TIA-1 (RTU; Zeta Corp, Sierra Madre, CA, USA). Immunoreactivity was detected using the Dako-labeled streptavidin-biotin detection kit, according to the manufacturer's recommended procedures. Twenty cases of non-specific HCC were evaluated by immunological staining using CD68 and CD163 for comparison.
Results
Clinical features of the patient with spontaneous regression of HCC
A 50-year-old man was admitted to hospital with a 3-month history of slight abdominal discomfort. There was no evidence of recent fever, acute hepatitis, or drugs. There was no previous history of heavy alcohol intake, operations, or blood transfusions.
The patient was positive for serological markers of HBV (HBsAg+, HBsAb-, HBeAg-, HBeAb+, and HBcAb+), but antibodies to HAV, HCV, HDV, HEV, and HGV were negative. The fetoprotein concentration level was 22,592.0 ng/mL (normal range, 0-9 IU/L). Investigations showed a normal white cell count. Aspartate aminotransferase activity was 53 IU/L (normal range, 8~40 IU/L); alanine aminotransferase activity was 70 U/L (normal range, 5~52 IU/L).
A liver tumor was first detected by ultrasonography. Ultrasonography showed isolated, large, highly reflective lesions suggestive of a tumor in the right lobe of the liver. Plain CT showed a nonuniform low-density area measuring 10.0 cm in diameter in Couinaud's segment 7 and 8 (S7~S8). Contrast-enhanced CT revealed the tumor to be partly encapsulated, enhanced for the most part, while it also had large low-density areas, suggesting necrosis ( Figure 1 ). Thus, massive-type liver tumors in the right lobe were diagnosed as HCC. At the same time, the possibility of a prior ischemic event cannot be confirmed by angiographic data and CT.
In May 2012, the patient underwent surgical resection by a right hepatectomy in the First Affiliated Hospital of Sun Yat-Sen University. About two years after surgery, he is still doing well and has no signs of recurrence.
Histopathological and immunophenotypic analysis of the patient with spontaneous regression of HCC
Macroscopically, the tumor on the cut surface of the specimen, measuring 10×9 cm, was yellowish and brown with a partially fibrous capsule and septum-like structures ( Figure 2 ). Microscopically, the tumor was an almost completely necrotic nodule with inflammatory cell infiltration, and was encapsulated by a fibrotic capsule. Hematoxylin and eosin Figure 3A) .
Approximately 1% survival of the malignant zone was noted ( Figure 3B, C) . The surviving part of the tumor was composed of large polygonal cells arranged in sheets, and trabeculae. Moreover, many inflammatory cells infiltrated the periphery of the tumor ( Figure 3D) . A minority of inflammatory cells infiltrated the central zone of the partially surviving tumor. Most importantly, we found macrophages located between surviving portions of the tumor cells ( Figure 3C ). They had abundant cytoplasm and large nuclei. We showed these cells to be activated. Concomitantly, the background liver contained active chronic hepatitis and mild liver fibrosis. Thus, the diagnosis of this patient was mostly spontaneous regression of HCC.
The Immunological staining using CD68 demonstrated individual positive cells in the central zone of surviving portion of the tumor, although an amount of cells was also found in the fibrous capsule of the periphery of tumor ( Figure 4A, B) . However, an odd phenomenon is that the densities of intratumoral CD163
+ cells were higher in partially surviving tumor than in the fibrous capsule and peritumoral liver tissue. Moreover, CD163
+ cells had a larger size with abundant cytoplasm in partially surviving tumors (Figure 4C-E) .
To confirm this odd phenomenon, 20 additional patients diagnosed with HCC, 20 tissue samples from 20 other patients with HCC (including HCC with massive necrosis or HCC without necrosis) by immunological staining, using CD68 and CD163. Small amounts of CD68 + and CD163 + cells could be detected in non-specific HCC ( Figure 5A, B) . The density and size of CD163
+ cells was lower in non-specific HCC than in the spontaneous regression of HCC ( Figure 5C ). The morphology of CD163
+ cells was similar to those in peritumoral liver tissue in non-specific HCC ( Figure 5D ). Therefore, we suspected that highly activated macrophages in tumor were a possible cause of spontaneous regression of HCC. The highly activated macrophages are CD163 + .
Discussion
Spontaneous regression of HCC is well documented. But the cause is a medical enigma in most cases. Spontaneous 
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Wang et al regression of HCC may be due to tumor ischemia, such as hepatic artery thrombosis. 10 The effect is similar to transcatheter arterial chemoembolization in the treatment of HCC. The inflammatory activation plays important roles in some cases of spontaneous regression of HCC. Determining the etiology of inflammatory reactions may help identify future therapeutic pathways for HCC immune-directed treatment.
In our case, we found that the odd phenomenon is that CD163 + macrophages are overactivated in surviving HCC that is spontaneously regressing. This is unusual. We cannot find a similar phenomenon in non-specific HCC. What explains this odd phenomenon? We considered two possible explanations. One explanation is that this overactivation is a reaction to tumoral necrosis, with scavenger receptor (CD163 + ) upregulation commensurate with the increased cell volume and phagocytic activity. But this could not explain the fact that the overactivated macrophages (CD163 + ) were most abundant in surviving tumors and lacking in the surrounding area of necrosis in our case. Moreover, we could not find the overactivated macrophages (CD163 + ) in our 20 cases of non-specific HCC, especially HCC with massive necrosis. Another explanation is that overactivated macrophages (CD163 + ) are the fundamental driving force behind spontaneous regression of HCC, although no other researchers have reported this discovery. We nonetheless prefer the latter explanation.
Most researchers accept that CD68 + is the most widely used marker for macrophages (pan-macrophages). Concomitantly, some reports have indicated that macrophages assume two different phenotypes based on environmental stimuli, the M1 (classically activated phenotype) and M2 (type II alternatively activated phenotype). CD68 could not distinguish between M1 and M2 subtypes. M2 macrophages have a high expression of several receptors such as CD163, which are polarized by anti-inflammatory molecules, such as interleukin-4 and interleukin-10, in order to show an immunosuppressive phenotype.
11
CD163 is a glycoprotein belonging to the scavenger receptor cysteine-rich superfamily. CD163-expressing cells have a role in regulation of the immune response because they can be controlled by various inflammatory mediators. 12 Recently, some researchers have paid attention to the role of macrophages in HCC, and have found that high abundance of macrophages was associated with poor prognosis of HCC. 13 Other researchers postulated that serum sCD163 was a new prognostic parameter in HCC patients.
14 Concomitantly, some research results showed that the local infiltration and plasma sCD163 of CD163 + cells were of limited significance in HCC, and that they were more likely markers related to active hepatitis rather than an indication of tumoral progression. 15 We considered that there is a relationship between macrophages and poor prognosis in HCC, because a lot of mac rophages infiltrated into peritumoral liver tissue, but not into tumors. This appearance was induced by the necrosis. Moreover, the activation of macrophages could release some cytokines, which leads to cell death. The balance between the necrosis and the infiltration of macrophages depended on different function of macrophages in tumors.
Furthermore, we observed in our case that the size of CD163 + cells in surviving tumors is obviously larger than the size of the same cells when they were located in peritumoral liver tissue. This prompted us to reason that the CD163 + cells in the surviving tumors of our case were activated when CD163 + cells in peritumoral liver tissue were dormant. We considered that CD163 could not distinguish between activated and inactivated macrophages. Therefore, the assessments of the quantity of CD163 + cells in tumor tissue were defective. We look forward to the advent of new molecular markers to detect activated macrophages.
Conclusion
A rare case of spontaneous regression of HCC, due mostly to necrosis, is presented in the present case report. In our case, we considered the overactivated macrophages (CD163 + ) in tumors to be dominant, although there are many macrophages whose morphology and immunophenotype are different to the overactivated macrophages in peritumoral liver tissue and non-specific HCC. Therefore, we considered that possible etiology of HCC spontaneous regression is that CD163 + macrophages are overactivated.
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